Client News

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Mallia Aesthetics Conducts Two Consumer Studies on Hair and Eyelash Growth with 8T3 Serums Based on sCD83

Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx

Rhovica Neuroimaging Secures CHF 2.3M (EUR 2.5M) Financing Led by M2care to Accelerate Development of SoNav™ Neurosurgical Device

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease

InflaRx Announces Participation in September Investor Conferences

Mallia Aesthetics Achieves Key Regulatory Steps for Novel sCD83-Derived Ingredient for Hair Growth

Nyxoah Reports Second Quarter Financial and Operating Results

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

Formycon Confirms Full-Year Guidance Following Business Development in line with Plan – Working Capital Raised